Learn how VIPER was used to gather data from electronic medical records and pathology systems in a report that demonstrate that implementation of a CMP reflex testing program is feasible and can ensure that a higher percentage of NSCLC pts receive molecular testing.
The recent discovery of relevant biomarkers has reshaped our approach to therapy selection for patients with non-small cell lung cancer. The unprecedented outcomes demonstrated with tyrosine kinase inhibitors in molecularly defined cohorts of patients has underscored the importance of genetic profiling in this disease.
Increasing enrollment into clinical trials is a top priority across the field of oncology. Because the vast majority of those afflicted with cancer receive their care in the community, creating strong clinical research programs in the community-based setting is important. This article comprehensively outlines the most important elements of creating and sustaining a successful community-based research program.
An AI-based platform, VIPER, triaged study participants across 20 different cancer studies simultaneously, allowing identification of patients for interventional studies (previously not attempted at a hospital due to resource constraints). See the poster for more information.
Our website contains links to websites owned and operated by third parties. If you use these links, you leave our website. These links are provided for your information and convenience only and are not an endorsement by Deep Lens of the content of such linked websites or third parties. Deep Lens has no control over the contents of any linked website and is not responsible for these websites or their content or availability.